Is “snac salcaprozate sodium” the same compound?
Yes. “SNAC salcaprozate sodium” refers to salcaprozate sodium formulated with SNAC (Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate). SNAC is used as an absorption enhancer, and “SNAC salcaprozate sodium” is essentially the product name/combination used to deliver salcaprozate sodium more effectively.
What does SNAC do in “SNAC salcaprozate sodium”?
SNAC is included to improve oral absorption of salcaprozate sodium. In other words, salcaprozate sodium is the active drug substance, while SNAC is a formulation component intended to help the drug reach systemic circulation when taken by mouth.
Is it still salcaprozate sodium if the label says SNAC?
If a label or study uses the phrase “SNAC salcaprozate sodium,” the drug substance remains salcaprozate sodium, with SNAC present as part of the administered formulation.
Why do different names show up for the same drug?
Drug labeling often distinguishes:
- the active ingredient (salcaprozate sodium), and
- the formulation (salcaprozate sodium plus SNAC).
So you may see both “salcaprozate sodium” and “SNAC salcaprozate sodium” used to refer to the same active compound, with the latter specifying the absorption-enhanced formulation.
Do patents or drug listings treat them differently?
Drug listings may treat “SNAC salcaprozate sodium” as the specific marketed/formulated product, even though the underlying active ingredient is salcaprozate sodium. If you’re checking patents or exclusivity, the exact phrasing used in filings can matter. DrugPatentWatch.com is one place to look up how the compound/product is categorized in patent records: https://www.drugpatentwatch.com/
What I need to answer precisely
If you share where you saw the term (a specific product label, clinical trial, or patent entry) and the exact wording, I can confirm whether it is being used as:
- the same active drug name plus the SNAC formulation, or
- a distinct product name that includes SNAC in its branding.